We are live on ! Find out more
CLRBZ

Cellectar Biosciences, Inc. Series A Warrants
CLRBZ

Delisted

CLRBZ was delisted on the 16th of April, 2021.

Back to rankings

2 hedge funds and large institutions have $518K invested in Cellectar Biosciences, Inc. Series A Warrants in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$20.5K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$518K +$20.5K +233,330 New
UBS Group
2
UBS Group
Switzerland
– -$1 -6 -0.2%

CLRBZ Hedge Fund Activity: Q4 2019 in Review

2 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q4 2019, worth a combined $518K.

Buyers outnumbered sellers: 1 fund opened new CLRBZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $20.5K. The largest seller was UBS Group, cutting an estimated $1.

  • 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q4 2019, up from 1 in Q3 2019.
  • Funds reported $518K of Cellectar Biosciences, Inc. Series A Warrants stock for Q4 2019.
  • 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q4 2019 and 0 closed out, a net change of +1 holder.
  • The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q4 2019 was Anson Funds Management, an estimated $20.5K added.
  • The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q4 2019 was UBS Group, an estimated $1 sold.

Based on aggregated 13F filings for Q4 2019.